Our aim was to measure the relative risks of Barrett ' s esophagus (BE) associated with demographic factors, measures of adiposity, and smoking among patients with gastroesophageal refl ux disease (GERD).
INTRODUCTION
Gastroesophageal re ux disease (GERD) is a major health problem in North America and Europe, with a high prevalence and considerable consequences for those a ected. e prevalence of GERD, de ned as at least weekly heartburn and / or acid regurgitation, is estimated to be 10 -20 % in the Western world (1) . Treatments are expensive (2, 3) , costing the United States approximately $ 9 billion annually (4) , and those with frequent GERD symptoms experience a decrease in the heathrelated quality of life (5, 6) . Furthermore, GERD is a strong risk factor for esophageal adenocarcinoma (EA) (7, 8) and its precursor, Barrett ' s esophagus (BE) (9 -12) . As the incidence of EA has increased in the United States more rapidly than any other cancer over the last 30 years (13 -16) , it is particularly important to identify factors which may in uence the conditions that lead to its development: GERD and BE.
Among persons with long-standing GERD symptoms, only about 10 -15 % actually develop BE in their lifetimes; among those who do, most do not progress to EA. erefore, there must be other cofactors modulating the re ux-related chronic in ammatory e ects on the esophageal epithelium. Case -control studies comparing BE cases to general population controls have identi ed abdominal obesity and cigarette smoking as possible risk factors for BE independent of GERD symptoms (17 -19) ; however, much less is known about factors that place GERD patients at higher risk for BE. Identi cation of such risk factors could help identify which GERD patients to endoscope, and could add to the prediction models being developed for this purpose (20) . In this report, we explore the association between BE and demographic factors, various anthropometric measures, and smoking history in a community clinic-based case -control study among patients with chronic GERD symptoms.
METHODS

Study participants
Cases were selected from among western Washington residents aged 20 -80 years without previously-diagnosed BE who underwent an upper endoscopy for the investigation of chronic GERD symptoms (e.g., heartburn, acid regurgitation, atypical chest pain, and / or belching), at one of ve community gastroenterology clinics between 1 October 1997 and 30 September 2000, as described earlier (18) . Brie y, potential participants were recruited in conjunction with their endoscopy visit. Cases were de ned as those with specialized intestinal metaplastic (SIM) epithelium on at least one of four standard four-quadrant biopsies taken just distal to the squamocolumnar junction for the purposes of this study. ese were evaluated by one of three University-based pathologists masked to endoscopy ndings. Of the 1,185 persons who consented to provide biopsies, SIM was found in 208 (17.6 % ). Of these patients, 193 (92.8 % ) were successfully interviewed. During the endoscopy, physicians recorded the presence and length of any visible columnar epithelium. Cases were subsequently classi ed into one to three of the following progressively exclusive groups: (1) SIM cases (i.e., all cases), (2) SIM and visible evidence of columnar epithelium (VBE), and (3) SIM and visible column epithelium greater than 2 cm (long segment BE, LBSE). e second two subgroups adhere to the case de nition of BE as described by the American College of Gastroenterology (21) , whereas the most inclusive group, SIM, is consistent with the concept of " ultra-short segment BE " (22 -24) . Eighteen cases (9.3 % ) were simultaneously diagnosed with adenocarcinoma ( n = 2) and / or dysplasia ( n = 0 high grade; n = 16 low grade); these were included in all analyses.
A random sample of approximately 50 % of the patients undergoing endoscopy for re ux symptoms, but who were biopsy-proven negative for SIM, were chosen to be used as GERD controls.
ese were frequency-matched to the distribution of cases on the month of biopsy and clinic. Of the 463 patients selected to be GERD controls, 419 (90.8 % ) were successfully interviewed.
is study was approved by the institutional review board of the Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Data collection
Cases and GERD controls underwent structured interviews by trained sta in their homes or another requested location approximately 1 -2 months a er endoscopy. e interview, which took about 45 min to complete, covered demographic characteristics, smoking and alcohol use history, diet, and relevant health and medication history. Interviewers measured participants ' height and weight, as well as waist, hip and thigh circumference using an established protocol (25) . All but two cases completed the portion of the interview with anthropometric measurements. Of the GERD controls, ve participants had partial measurements done and three refused.
Antibody levels to Helicobacter pylori were available for the rst 50 cases and 97 GERD controls using a total antibody latex agglutination assay kit (Orion Diagnostica, Espoo, Finland) (26) .
Statistical Analyses
Multivariate unconditional logistic regression with robust standard errors was used to calculate adjusted odds ratios (aORs) and 95 % con dence intervals (CI) using Stata / SE (version 9.1) (27) .
Demographic factors and measurements of adiposity and smoking were divided into potential risk categories, with the low-risk category used as the referent group. Demographic factors examined included age assessed continuously and categorically ( < 50 years old / 50 + ), gender, race (White / Black / Asian American / other), and education (high school or less / technical school / college or more). Measures of adiposity examined included body mass index (BMI) (kg / m 2 ), waist circumference (cm) (WC), waist-tohip ratio (WHR), and waist-to-thigh ratio (WTR). The categories used for BMI ( < 25 / 25 -29.99 / 30 + kg / m 2 ), as well as the gender-specific categories used for WC (male, low / medium / high: < 93 / 94 -101.99 / 102 + cm; female, low / medium / high: < 79 / 79 -87.99 / 88 + cm), and WTR (male, low / medium / high: 0.97 -1.66 / 1.66 -1.80 / 1.80 -2.72; female, low / medium / high: 1.02 -1.42 / 1.42 -1.61 / 1.62 -2.4) were those used and discussed in a recent report from this study (18) . In that report, the WHR high-risk category was 0.9 + for males and 0.85 + for females. However, when examining the risk of BE by 0.05-increments for this investigation, substantial risk of BE was found in lower values of WHR for females, although not in males. Thus, in this investigation the high-risk categories for the binary categorization of WHR are 0.9 + for males and 0.8 + for females. We also present the relative risks by 0.05-increments of WHR.
A history of cigarette use was analyzed in four di erent forms: ever / never binary, current / ever / never categorical, total pack-years in three categories as de ned by the median of the entire study population (never / < 13.5 / 13.5 + ), and years since cessation. Alcohol consumption was evaluated for beer, wine, and liquor separately based on a lifetime-averaged frequency of drinks (weekly / < weekly daily / daily + ). Heartburn and acid regurgitation frequency were categorized similarly.
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e potential confounding e ects of age, gender, race, and education level as well as design variables, clinic, and time period of endoscopy (1998 -1999 / 2000 -2002) , were assessed, and factors that made more than a 10 % di erence in the ORs for an appreciable number of associations were included in adjusted models, along with measures of obesity and cigarette smoking. Trend tests were based on using continuous measures in the logistic regression models for age, BMI, WC, WHR, WTR, pack-years, and years since smoking cessation, with all but age considered in natural logarithm form in addition to untransformed continuous. Strati ed ORs presented are based on logistic regression models that included interaction coe cients between the subgroup classi cation of interest and WHR.
RESULTS
Table 1
presents selected sociodemographic characteristics of cases and GERD controls. Of 197 cases with SIM, 97 were VBE cases and, of those, 54 were cases of LSBE. All participants reported at least one GERD symptom. e most common symptom was heartburn (92 % of both cases and GERD controls), with 77 % GERD controls and 76 % of cases reporting a frequency of at least once per week.
Older age and male gender were associated with increased risk for each of the case groups ( Table 2 ). Relative risks associated with older age were quite similar across case groups (age per decade aOR for SIM = 1.3, 95 % CI = 1.1 -1.5; VBE aOR = 1.4, CI = 1.1 -1.6; LSBE aOR = 1.5, CI = 1.2 -1.9). In contrast, the strength of the association with male gender increased from SIM to LSBE. Compared with White participants, Asians were at increased risk for all three case groups, whereas those of African or other ancestry were at reduced risk. Similar results for race and age were found for SIM-only cases, (i.e., the 96 participants with SIM who had no visible columnar epithelium); however, in this group there was no association seen with gender.
Among the measures of adiposity, WHR and WTR were the strongest predictors of risk for both the VBE and LSBE case groups ( Table 2 ). e associations with BMI and WC were not as strong and generally lacked statistical signi cance. An exception was that among all SIM cases there was a signicant positive trend for BMI. is could be wholly attributed to a moderately strong association with BMI in the SIM-only case group (BMI 25 -29.99, aOR = 2.3, CI = 1.1 -4.5; BM ≥ 30, aOR = 2.7, CI = 1.4 -5.4.).
When WHR and BMI were modeled simultaneously, the association between WHR and all SIM cases lost strength (aOR = 1.1, CI = 0.7 -1.8) and BMI estimates were relatively una ected. In contrast, the association of WHR with VBE (aOR = 2.0, CI = 1.0 -3.9) and LSBE (aOR = 4.0, CI = 1.4 -11.6) remained strong and the estimates for association of BMI with these case groups were reduced to near unity. Similar results were seen when WTR was used in place of WHR. None of the associations presented in the Table 2 were appreciably a ected when adjusted for race, education, time period of endoscopy, frequency of heartburn, acid regurgitation, or alcohol consumption. Figure 1 illustrates that for most gender-speci c case groups, a er the initial increase, there was no substantial further increase in the ORs for each of the 0.05-increment WHR. When modeled continuously either as natural log continuous ( Table 2 ) , untransformed continuous or in 0.05-increments, the trend tests were not statistically signi cant. A similar threshold by gender was seen when WTR was modeled.
e associations between WHR and risk of all three case types tended to be stronger among those with a BMI of 25 or greater and those with at least weekly GERD symptoms GERD, gastroesophageal refl ux disease.
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A Community Clinic-Based Case -Control Study ( Table 3 ). In contrast, there was no apparent pattern in variation of ORs in strata de ned by age, gender, smoking history, or race (race data not shown). None of the variations in OR described in Table 3 was statistically signi cant.
A history of ever-smoking cigarettes was signi cantly associated with each of the case groups when adjusted for age, gender, WHR, and clinic ( Table 4 ) , with little evidence of a dose -response relationship when smoking was measured in pack-years (all P values of trend tests ≥ 0.05). Smoking cessation was not observed to decrease risk. ese estimates were not appreciably di erent when further adjusted for race, education, time period of endoscopy or frequencies of heartburn, acid regurgitation, or alcohol consumption. In contrast, in the SIM-only case group, there was weak evidence of a doseresponse relationship: relative to nonsmokers, current smokers were at higher risk (aOR = 2.3, CI = 1.2 -4.5) than former smokers (aOR = 1.9, CI = 1.1 -3.2), and the trend test for pack-years was statistically signi cant ( P < 0.0.01). In the small number of cases (SIM, n = 50; VBE, n = 19; LSBE, n = 10) and GERD controls ( n = 97) in whom antibody levels had been measured, WHR and male gender were associated with risk among those who were H. pylori negative (WHR OR = 2.1, CI = 0.9 -5.6; male OR = 1.6, CI = 0.7 -4.1), but not those who were H. pylori positive (WHR OR = 1.1, CI = 0.4 -3.5; male OR = 0.9, CI = 0.3 -2.6) in unadjusted analyses. In contrast, the association between SIM and history of cigarette smoking (ever / never) or age ( < 50 / 50 + or by decade) were similar in the two groups.
DISCUSSION
In this community clinic-based case -control study, we observed a number of factors that increased risk for SIM and BE among patients with chronic GERD symptoms. Older age, male gender, and possibly Asian race were associated with increased risk independent of other proposed risk factors for BE. Measures of central adiposity, WHR, and WTR were also associated with case status, with relative risk increasing from SIM to VBE and from VBE to LSBE. Risk did not increase appreciably once a gender-speci c threshold was reached. e association with WHR was independent of BMI for VBE and LSBE cases, whereas in the SIM case group, the relationship lost strength when adjusted for BMI. e relationship between BE and WHR was stronger in patients with more frequent GERD symptom and those with BMI ' s greater than 25 kg / m 2 . We observed a moderately increased risk of BE with a history of cigarette smoking, but little evidence of a dose -response relationship with intensity ere was no association between any of the case groups and Hispanic origin, education or any type of alcohol consumption when adjusted for age, gender, cigarette smoking, WHR, and clinic (data not shown). In an unadjusted analysis, drinking beer daily or more frequently was associated with all case groups; the strongest association was in the LSBE group (crude OR = 2.7, CI = 1.3 -5.7). However, adjustment substantially reduced the strength and statistically signicance of these associations (e.g., LSBE aOR = 1.2, CI = 0.5 -3.1), with gender and cigarette smoking history as the major confounding factors. High WHR defi ned as ≥ 0.9 for males and ≥ 0.8 for females.
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A Community Clinic-Based Case -Control Study or duration of smoking, and no evidence of decreased risk with cessation. Barrett ' s esophagus is traditionally thought of as a disease of middle-aged and older white men (9, 28) , and most of our results support this demographic pro le. We are unaware of other studies that performed a multivariate analysis to investigate these demographic factors among patients with chronic GERD symptoms, although the increasing risk of BE associated with increasing age that we observed is consistent with three recent studies that compared BE cases with patients undergoing endoscopy for any indication (29 -31) . Furthermore, two of these studies appear to support our nding that the relationship with age may not change by case group, with one study in Sweden reporting statistically signi cant aORs for age of 1.05 per year (approximately 1.6 per decade) for patients in case groups with similar de nitions to our SIM and VBE groups (30) and another in the United Kingdom (29) reporting an statistically signi cant aOR of 1.03 (approximately 1.3 per decade) in an LSBE case group.
Male gender was identi ed as a strong risk factor in the UK study (29) , as well as in a multicenter investigation in the United States (31) , which also used LSBE as its case de nition. In contrast, no signi cant relationship between gender and risk of SIM and VBE was observed in the Swedish study (30) . Male gender as a risk factor for BE is also supported by the predominance of males among BE cases reported in numerous studies, regardless of whether BE is de ned by SIM or columnar epithelium-line esophagus (32) . e increase in strength of the association with male sex from SIM to VBE and from VBE to LSBE in our study was similar to that observed in data presented by Hirota et al. (33) , in which there was an increase in the male / female sex ratio from short-segmented BE cases to LSBE. In addition, reports have noted increased presence and severity of erosive esophagitis among males, suggesting that males may experience increased severity of re ux or susceptibility to its immediate complications (34, 35) .
Although our study population was mainly White, consistent with BE studies among patients undergoing endoscopy (31,36) , we detected lower risk for Blacks for SIM and no Black case participants with VBE. Participants of Asian origin appeared to be at higher risk for BE than Whites, which was unexpected. Despite the small number of Asian participants in our study, this nding was statistically signi cant in the overall group (SIM) and increased risk was found in all three case groups. is contrasts with two other studies carried out in US populations, in which Asian Americans were at lower risk of BE (31, 37) . It is possible that the ndings in the SIM group are due to its heterogeneity, as it likely includes a substantial proportion of cardia metaplasias, for which Asians are likely at higher risk due to H. pylori pangastritis. We note that the ndings in the VBE and LSBE groups are particularly limited by small sample size, and suggest that further inves- gests that central adiposity and obesity may act together in increasing risk of BE development. us, those chronic GERD patients with both a high BMI and signi cant central adiposity may be a potential targets for screening and prevention e orts. Another subgroup that may be important is those with high WHR and frequent re ux symptoms. e potential interaction between the two among GERD patients is consistent with studies comparing either BE or EA cases to population controls (18, 19) . One possible biological explanation for the relationship between BE and central adiposity is that the adipocyte ' s extensive metabolic activity may play a role in promoting BE and EA. A number of bioactive substances (adipokines) are produced in excess of normal in visceral fat, including free fatty acids, leptin, and in ammatory cytokines (41 -43) . One consequence of this metabolic activity, particularly the production of fatty acids, is the development of insulin resistance (44, 45) and resulting hyperinsulinemia, which can have direct e ects on tumor development by promoting proliferation and inhibiting apoptosis and increasing IGF bioavailability (46) . Adiponectin is found in decreased concentrations among overweight persons, and it has been negatively correlated with a number of obesity-related cancers (47) , perhaps due to the absence of its anti-in ammatory e ects (47, 48) . Proinammatory cytokines and receptors, such as interleukin-6, tumor necrosis factor-, and leptin, are produced in signicant amounts by adipocytes, particularly those in the visceral compartment (41,49 -53) . Leptin can also promote cancer through mitogenic and angiogenic mechanisms (54) . Comparing BE cases with population controls, Kendall et al. (55) observed an association between leptin and BE independent of BMI in males but not females. In a smaller pilot analysis, they found no relationship between BE and adiponectin for either gender. Given that there is evidence of a relationship between central adiposity and BE risk in women, it seems that more research is needed to investigate the apparently discrepant results.
Our results regarding smoking, including the lack of a doseresponse relationship with increasing cumulative exposure and strength of estimates, are consistent with recent case -control studies based on the population controls (18, 19) . Although, cigarette smoking was found to be signi cantly associated with each of the case groups that included those with visible evidence of columnar epithelium, it did not show a pattern of increasing risk by case group, as was found by Johnasson et al. (30) . is and the dose -response seen in the SIM-only case group suggests that it is a risk factor for metaplasia of the gastric cardia (56) in addition to BE.
Strengths to our study include its design, breadth and depth of risk factors measured, standardized case classi cation, and clinic-matched controls that were quite similar to cases in reporting of chronic GERD symptoms. is study is one of the rst to examine the relative risk of BE among individuals with chronic GERD and multiple measures of overweight and central adiposity, including BMI, WC, WHR, and tigation is needed into risk of SIM and BE associated with Asian race.
Central adiposity was a risk factor for SIM and BE among our study population with chronic GERD symptoms. e strength of the associations between either WHR or WTR and the BE case groups were not as strong as we found in our study comparing these BE cases to population controls (18) , which is consistent with Corley et al. (17) study's results comparing VBE cases to GERD and population controls using WC and WTR as measures of central adiposity. is suggests that central adiposity plays a role in at least two steps of EA disease progression: from healthy to chronic GERD, and from GERD to BE. Comparing VBE cases with GERD controls, Corley et al. also found evidence of a trend of increasing risk with increasing WC, with no evidence of a threshold e ect. Interestingly, this threshold e ect was observed for both WC and WTR in the analysis with population controls as the comparison group.
In terms of BMI, evidence from this investigation, and others including a recent meta-analysis by Cook et al. (17, 30, 32, 38) , strongly suggests that BMI is not a risk factor for BE among those undergoing endoscopy. However, the trend seen for BMI in the SIM-only case group, independent of WHR, suggests that BMI plays a role in early in the development of BE. Alternatively, as discussed above, this association may result from the heterogeneity of the SIM group, as distinguishing metaplasia of the gastric cardia from metaplasia of the esophagus and gastroesophageal junction using clinical or histopathological criteria can be problematic. us, if measures of central adiposity are causally related to the development of BE among those with chronic GERD, but not to gastric cardia metaplasia, then one would expect the strongest associations to be found in the most speci c case group: LSBE.
Another approach to addressing the heterogeneity of the overall case group was our exploratory analysis focused on the H. pylori negative SIM cases, under the assumption that H. pylori positive cases were more likely to represent H. pyloriinduced gastric cardia metaplasia. e results were consistent with this line of reasoning: among H. pylori negative cases, the association between risk of SIM and WHR was strong, whereas there was no association in the H. pylori positive group. It is also possible that the e ect of central adiposity on the risk of SIM is less among persons with H. pylori gastritis due to less acidic re uxate (39) . is di erence by H. pylori status was also seen to a lesser extent in the association between SIM and gender, but not the association with age or cigarette smoking. Regarding gender, these observations are consistent with the lack of gender association with gastric cardia metaplasia as reported by El-Serag et al. (40) ese observations should be interpreted cautiously, though, as they are based on a small number of participants with antibody measurements and were analyzed in the SIM group, which is the least speci c case group.
e stronger association seen between WHR and BE in the subgroup of participants with higher BMI ( Table 4 ) sug-WTR. Furthermore, we were able to classify cases by their endoscopic appearance, as well as histologically through a standardized protocol, which included four quadrant biopsies interpreted by a small number of university-based pathologists.
ere are potential limitations as well. It is possible that GERD patients receiving an endoscopy and agreeing to undergo our initial screening process may not be representative of all GERD patients. Although our participation rate was high (>90 % ) among cases and GERD controls that underwent the initial screening process, we were unable to determine the rate of refusal among all endoscopy patients at the participating clinics and whether those not included di ered in some way to the cases studied. It was not always feasible to blind the interviewers as to case status, though they were not told of the speci c hypotheses that would be examined, and it seems unlikely that their knowledge of case status biased the interview or physical measurements in important ways. Also, we had limited sample size for some of our analyses, particularly those regarding Asian race and results strati ed by H. pylori status.
We conclude that central adiposity is a risk factor for BE among GERD patients, suggesting that it may be used as a factor in screening for endoscopy, perhaps more e ectively in patients that also have more frequent GERD symptoms and / or have higher BMIs. We also conclude that at least some of the e ects of older age and male gender on risk of EA manifest themselves in the transition from GERD to BE, possibly by increased severity of re ux or increased susceptibility to its e ects . A history of cigarette smoking also predicted risk of BE, although we found no evidence of increased risk with increasing cumulative exposure, and no evidence of decreased risk with smoking cessation. ese observations underscore the need for additional research focused on developing risk pro les for screening GERD patients that include age, sex, smoking and central adiposity, as well as continued research in identi cation of the mechanisms underlying the role of obesity in promoting BE and EA.
